Artelo Biosciences Inc (ARTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,916 | 6,888 | 7,136 | 12,122 | 10,350 |
| Marketable Securities | 8,567 | 9,150 | 10,859 | 7,211 | 11,162 |
| Other current assets | 0 | 1,495 | 1,622 | 2,123 | 1,999 |
| TOTAL | $16,386 | $18,322 | $20,303 | $22,282 | $24,589 |
| Non-Current Assets | |||||
| Intangibles | 2,039 | 2,039 | 2,039 | 2,039 | 2,039 |
| Other Non-Current Assets | 53 | 63 | 73 | 84 | 76 |
| TOTAL | $2,092 | $2,102 | $2,112 | $2,123 | $2,115 |
| Total Assets | $18,478 | $20,424 | $22,415 | $24,405 | $26,704 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 788 | 958 | 438 | 482 | 843 |
| TOTAL | $825 | $998 | $480 | $527 | $875 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 15 | 23 | 32 | 40 | 49 |
| TOTAL | $15 | $23 | $32 | $40 | $49 |
| Total Liabilities | $840 | $1,021 | $512 | $567 | $924 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 476 | 476 | 476 | 474 | 470 |
| Common Shares | 3 | 3 | 3 | 42 | 42 |
| Retained earnings | -33,189 | -31,021 | -27,682 | -25,352 | -22,903 |
| Other shareholders' equity | -205 | -254 | -388 | -176 | -64 |
| TOTAL | $17,638 | $19,403 | $21,903 | $23,838 | $25,780 |
| Total Liabilities And Equity | $18,478 | $20,424 | $22,415 | $24,405 | $26,704 |